Clinical Case Reports (Mar 2019)

Use of botulinum toxin in Frey's syndrome

  • Francesco Freni,
  • Francesco Gazia,
  • Ferdinando Stagno d’Alcontres,
  • Bruno Galletti,
  • Francesco Galletti

DOI
https://doi.org/10.1002/ccr3.2019
Journal volume & issue
Vol. 7, no. 3
pp. 482 – 485

Abstract

Read online

Key Clinical Message Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surgery and the first treatment.

Keywords